# Ketorolac for Analgesia followiNG Autologous Breast RecOnstructiOn

> **NCT03007381** · PHASE4 · WITHDRAWN · sponsor: **Nova Scotia Health Authority**

## Conditions studied

- Breast Cancer Female

## Interventions

- **DRUG:** Ketorolac Tromethamine
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT03007381
- **Lead sponsor:** Nova Scotia Health Authority
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-11
- **Primary completion:** 2019-01
- **Final completion:** 2019-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No funding.
- **Last updated:** 2017-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03007381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03007381, "Ketorolac for Analgesia followiNG Autologous Breast RecOnstructiOn". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03007381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*